Wang Zichuan, practicing lawyer since February 2023, senior legal advisor, and renowned author. She previously served as a legal counsel and senior executive in the internet medical company ATD, where she gained familiarity with the biopharmaceutical, medical industry, and entertainment sector.
Ms. Wang has a multi-interdisciplinary professional background. She is skilled at combining a company’s operations and the current state of the industry to resolve a range of complex issues that arise during a company’s growth, such as corporate governance, structural design, equity incentives, investment, financing, mergers and acquisitions, intellectual property rights, and asset disposal, in accordance with the company’s current status and future plans, as well as its specific needs. Ms. Wang is adept at guiding small and medium-sized enterprises through the process of compliance transformation and standardizing competitive business practices, safeguarding a company’s intangible assets, and assisting companies in maximizing the use of intellectual property to boost new quality productivity. Additionally, she is proficient in assisting high-tech enterprises with experimental ethical and compliance during the research and development phases of cutting-edge technologies and First-in-class patent innovations, and in establishing and perfecting systems for managing core scientists and research teams.

Providing legal services in corporate governance, investment and financing, IPO, restructuring, mergers and acquisitions, intellectual property, and intellectual property financialization for high-tech enterprises in the biopharmaceuticals, medical, entertainment, semiconductor, new energy, new materials, and high-tech enterprises.

Assisted Chenghui Medical Co., Ltd. (Stock Code: 870856) in its listing on the NEEQ (National Equities Exchange and Quotations). Provided specialized legal advisory services for the NAD+ patent pool planning of Munon Biotech.
Handled the licensing of boron neutron drug patents for Professor Lai Hongsen of Tufts University, USA.
Represented the series of unfair competition disputes between "Golden Buddha Thai Herbal Balm" and "Yingdi Thai Herbal Balm."
Represented Guangzhou Keyu Medical Aesthetics Hospital in a series of medical malpractice liability disputes with clients.
Provided specialized legal services for the legal opinion on the 2024 Annual General Meeting of Shareholders for Orange Interactive (Stock Code: 870110).
Served as long-term legal advisor and conducted due diligence on investment and financing for CIMC Transportation and its 13 subsidiaries.
Provided specialized legal advisory services for Zhongke Fenyang’s acquisition of SanSanLing Semiconductor.
Conducted due diligence and issued a legal opinion on financial write-offs for ShenZhongDian.
Handled construction engineering disputes involving Feiling Intelligent and companies such as Donghai Airlines, Yijian, Tongda Electromechanical, and Pangchuan.
Conducted due diligence for XinHaoyuan Co., Ltd. and Zhongqichen in an asset restructuring project.

Member of the Guangdong New Social Stratum Association
Member of the Guangdong Writers Association and Guangdong Writers' Rights Protection Committee
Member of the Shenzhen Intellectual Property Finance Association
Invited Mediator of the Copyright Mediation Committee of the Shenzhen Copyright Society